Sana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates

SANA Stock  USD 3.16  0.35  12.46%   
About 56% of all Sana Biotechnology's investors are looking to take a long position. The analysis of the overall investor sentiment regarding Sana Biotechnology suggests that some traders are interested. The current market sentiment, together with Sana Biotechnology's historical and current headlines, can help investors time the market. In addition, many technical investors use Sana Biotechnology stock news signals to limit their universe of possible portfolio assets.
  
Goal to treat 40-60 patients in 2024 in four trials across seven indications in oncology, B-cell mediated autoimmune diseases, and type 1 diabetes Early...

Read at globenewswire.com
Macroaxis News: globenewswire.com
  

Sana Biotechnology Fundamental Analysis

We analyze Sana Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sana Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sana Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Retained Earnings

Retained Earnings Comparative Analysis

Sana Biotechnology is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.

Sana Biotechnology Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sana Biotechnology stock to make a market-neutral strategy. Peer analysis of Sana Biotechnology could also be used in its relative valuation, which is a method of valuing Sana Biotechnology by comparing valuation metrics with similar companies.

Peers

Sana Biotechnology Related Equities

ZNTLZentalis Pharmaceuticals   12.50   
0%
100.0%
GBIOGeneration Bio   9.68   
0%
77.0%
LYELLyell Immunopharma   5.17   
0%
41.0%
NKTXNkarta   4.25   
0%
34.0%
AMLXAmylyx Pharmaceuticals   3.62   
0%
28.0%
OLMAOlema Pharmaceuticals   2.90   
0%
23.0%
XFORX4 Pharmaceuticals   2.00   
0%
16.0%
GLUEMonte Rosa   0.89   
0%
7.0%
KYMRKymera Therapeutics   0.68   
0%
5.0%
DAWNDay One   0.41   
0%
3.0%
APLSApellis Pharmaceuticals   0.22   
1.0%
0%
TERNTerns Pharmaceuticals   0.49   
3.0%
0%
HOOKHookipa Pharma   0.53   
4.0%
0%
CGEMCullinan Oncology   0.63   
5.0%
0%
BPMCBlueprint Medicines   1.31   
10.0%
0%
RVMDRevolution Medicines   1.57   
12.0%
0%

Complementary Tools for Sana Stock analysis

When running Sana Biotechnology's price analysis, check to measure Sana Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sana Biotechnology is operating at the current time. Most of Sana Biotechnology's value examination focuses on studying past and present price action to predict the probability of Sana Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sana Biotechnology's price. Additionally, you may evaluate how the addition of Sana Biotechnology to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Bonds Directory
Find actively traded corporate debentures issued by US companies
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals